Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Home

Header Top Menu

  • News & Featured Stories
  • Media
  • Careers
  • Contact Us
  • Our Science

    Sub Menu 1

    • Pfizer in the UK
      • Our History
      • Pharmaceutical Sciences
      • Devices Centre of Excellence
      • Global Regulatory Affairs
      • Material Characterisation Team
      • Anti-Counterfeit Laboratory
    • Our Therapy Areas
      • Anti-Infectives
      • Inflammation and Immunology
      • Internal Medicine
      • Oncology
      • Rare Disease
      • Vaccines

    Sub Menu 2

    • Developing New Medicines
      • Clinical Trials
      • Pipeline
    • Research partnerships
      • ADDoPT
      • Innovative Target Exploration Network (ITEN)
      • INSPIRE Programme
      • Medical Research Council Collaboration
      • The Stratified Medicine Programme
      • Partnership with Regeneron for UK Biobank exome sequencing
    • Breakthroughs that change patients’ lives
    Hot Topic

    Re-shaping Cancer

    Re-shaping cancer
  • Products

    Sub Menu 4

    • Prescription medicines

    Sub Menu 5

    • Safety of Medicines
      • Medicines Regulation
      • Reporting Side Effects
      • Counterfeit Medicines
    Hot Topic

    Vaccines partnerships

    Vaccines partnerships
  • Responsibility

    Sub Menu 7

    • Transparency
      • HCP & HCO Annual Disclosure Reports
      • Healthcare Organisation Grants
      • Research and Development Funding
      • Patient Organisation Funding and Support
    • Codes of Conduct
      • Gender Pay Gap Report
      • Section 172 Statements
      • Pfizer UK Modern Slavery Statement
      • Pfizer UK Tax Strategy

    Sub Menu 8

    • Environmental Sustainability
      • Climate Action
      • Global Actions
      • Our Partnerships & Commitments
      • Sustainable Medicines
      • UK Actions
    • Insurance Details
    • Animal Welfare
    Hot Topic

    Putting Patients First

    Putting Patients First
  • UK Society

    Sub Menu 10

    • Social Investment
      • Volunteering and Fundraising
      • Medicines Donations
    • Raising Public Awareness
      • Change the Course
      • Pfizer Sponsors Science Museum Group's 'Cancer Revolution' Exhibition
      • Pfizer Sponsors the Superhero Series
      • Pfizer sponsors Science Museum exhibition 'Superbugs'
      • Pfizer at the British Science Festival
      • Turning Heads at Westminster

    Sub Menu 11

    • Science Education
      • Developing Science Talent
      • 'Superbugs Join The Fight' School Programme
      • Online Learning
        • Student Education Area
        • Teacher Resources
      • Community Lab
      • Career Talks
      • Lab in a Box
    • Pfizer Worldwide
      • Global Health Fellows
      • Global Aid and Emergency Relief
      • International Trachoma Initiative
    Hot Topic

    'Superbugs' Competition Winners

    Superbugs Winners
  • UK Health System

    Sub Menu 16

    • Working with the NHS and other Healthcare Organisations
      • Collaborative Working
        • Collaborative Working Project between Lloyds Pharmacy and Pfizer Vaccines
        • Joint Working
      • Donations and Grants
        • Independent Medical Grants and Donations
        • Donations of Goods, Services and Benefit in Kind
        • Grants
        • Donations and Grants Enquiry Form
    • Working with Healthcare Professionals
      • FAQs: Working with Healthcare Professionals
      • Pharmacy
      • Healthcare Professionals Congress Sponsorship

    Sub Menu 17

    • Working with Patient Organisations
      • Patient Involvement in Research and Development
      • Our ongoing partnership with the UK Sepsis Trust
      • Partnering with the NIHR and young people on clinical research
    • Pfizer Healthcare Hub
      • Pfizer Healthcare Hub: 2018
      • Pfizer Healthcare Hub: 2017
      • Connect with the Hub
    Hot topic

    Osteoarthritis

    Osteoarthritis
  • News & Featured Stories
  • Media
  • Careers

    Carrers

    • Search Current Vacancies
    • Apprenticeships
      • Apprenticeship Vacancies
    • Undergraduate Placements
      • Undergraduate Vacancies
    • Meet our people
    • UK Top Employer
    • How Pfizer is fostering meaningful growth for every colleague, everywhere
  • Contact Us
  • Footer links

    Footer mobile menu

    • Footer Menu
    • Footer menu
      • Contact Us
      • Cookie Policy
      • Terms of Use
      • Privacy Policy
      • Sitemap
    • Footer social item
      • Facebook
      • Twitter
      • Instagram
      • YouTube

Optimism over despair: Why we need to maintain our momentum through COVID-19 to change the course of antibiotic resistance

Optimism over despair: Why we need to maintain our momentum through COVID-19 to change the course of antibiotic resistance
News & Featured Stories/ Optimism over despair: Why we need to maintain our momentum through COVID-19 to change the course of antibiotic resistance
04/03/2021

Pfizer Anti-Infectives
Pfizer UK

For many of us, COVID-19 has been the single biggest global crisis we've ever lived through. As the pandemic continues to impact on families and businesses around the world, we have a duty to maintain the momentum of a global, collaborative response to save lives before it’s too late.

 

It remains that while the impact of the pandemic has been widely reported on, few people are focused on how COVID-19 is accelerating the threat of antibiotic resistance. A recent review of data from over 30,000 COVID-19 cases globally, found that 74% of patients received antibiotics despite only 8% having bacterial coinfections.1 The study suggests that a large number of antibiotics are being prescribed unnecessarily, increasing the risk of antibiotic resistance – particularly in areas where it’s already a significant problem. Similar concerns have been raised in the US where researchers have tracked the rise of a resistant superbug (Candida auris) in hospitals hit hard by COVID-19.2 This is deeply concerning for all those involved in antimicrobial stewardship efforts to minimise the risk of resistance.

Yet we’ve seen what can be accomplished when industry, government, our healthcare system and academia come together to control infections and protect lives. Whole organisations are putting competitive differences aside to tackle the COVID-19 crisis, moving together with unprecedented speed to find solutions, and we should be doing the same for antibiotic resistance.

Many key interventions in the control of COVID-19 are also critical in the fight against antibiotic resistance; for example, pushing for patients to be routinely screened for infection, keeping vaccinations up to date and conducting tests to determine which class of treatments should be administered to alleviate the infection. These actions can help ensure people get the right medicines at the right time, as well as helping to manage future outbreaks through better tracking of infections.

A poll conducted by Pfizer UK showed that public knowledge about antibiotic resistance is increasing – at 70% in 2020, compared to only 54% in 2019." 

It is also fair to say that we all now understand our individual responsibility to prevent infections and protect those around us. For several months now, we’ve committed to taking extra precautions like washing our hands at every given opportunity and wearing masks in public places. These actions have a real impact on preventing infections, and maintaining momentum is crucial to ensure we continue acting in ways that prevent bacterial infections and overuse of antibiotics in our lifetime.

A poll conducted by Pfizer UK showed that public knowledge about antibiotic resistance is increasing – at 70% in 2020, compared to only 54% in 2019.3 While this is moving in the right direction, almost half of people (45%) in the UK don’t know what action they can take to address the issue.

This is why we created Change the Course – a new initiative developed to equip the public with actions they can take to reduce the threat of antibiotic resistance. In a new report authored by an independent group of experts, readers can access the latest information about antibiotic resistance and how to act in ways that can make a difference. These include:
 

Spreading the word

 

 

 

  • Considering how yourself and others may have already been affected by antibiotic resistance.
  • Joining others in the global movement who are already talking about the issue.
  • Sharing the report and talking positively about the action you’re taking.

Calling for action

 

 

 

  • Making your voice heard by sharing your stories, concerns or ideas with your Member of Parliament, local councillors or community leaders.
  • Finding out how antibiotics are used in food production and calling for action by starting online conversations and petitions.

Joining the learning revolution

 

 

 

  • Taking advantage of educational resources, designed to help anyone, at any age, to understand the real-world issue of antibiotic resistance.
  • Getting involved in citizen science to help support current research that could identify new antibiotics.

Supporting the good work

 

 

 

  • Getting behind some of the leading charities and non-profits tackling antibiotic resistance to support with education, fundraising and donations.

 

References

  1. Langford BJ, So M, Raybardhan S, et al Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Accessed Nov 2021
  2. ‘Cousins, S., 2020. 'Drug-resistant superbug thriving in hospitals hit hard by COVID-19.’ National Geographic. Accessed Nov 2021
  3. Data on file. Pfizer UK survey.
  4. Data on file. Pfizer UK survey.

 

PP-PFE-GBR-4208 / November 2021

Related Hot Topics
AMR Reimbursement Pilot Launch
World First Cross-Industry Initiative Launches in the Continued Fight Against…
What is a Variant
What is a Variant?
COVID-19 Vaccine Equity
Working To Reach Everyone, Everywhere
VacciNation report
VacciNation: tackling health inequalities across England
Patients at heart of clinical trials
Why putting patients at the heart of Pfizer UK’s clinical trials continues to…
AMR Explained
Antimicrobial Resistance Explained
Infection Management Coalition Paper
Cross-Industry Coalition Tackling ‘Hidden Pandemic’ of Antibiotic Resistant…
Blueprint for gene therapy adoption
Pfizer UK launch blueprint for the UK adoption of cell and gene therapies
Tags
Anti-Infectives
COVID-19
UK Health System

Footer

  • Contact Us
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • Sitemap

Footer aside

  • Footer Aside
    • Facebook
    • Twitter
    • Instagram
    • YouTube

Copyright © 2017-2022 Pfizer Limited. PP-PFE-GBR-4248 / Nov 2021. All rights reserved. Registered in England and Wales No. 526209. Registered office: Ramsgate Road, Sandwich, Kent CT13 9NJ. VAT No. GB201048427